Literature DB >> 1833773

Affinity purification of Trypanosoma brucei small nuclear ribonucleoproteins reveals common and specific protein components.

Z Palfi1, A Günzl, M Cross, A Bindereif.   

Abstract

We have developed a procedure for the affinity purification of small nuclear ribonucleoproteins (snRNPs) of Trypanosoma brucei (U2 and U4/U6 snRNPs), which are essential for trans splicing. Each of these snRNPs can be specifically and efficiently selected from T. brucei extracts through biotinylated antisense 2'-O-methylated RNA oligonucleotides immobilized on streptavidin-agarose. Protein analysis revealed a set of five low molecular weight polypeptides common to the U2 and U4/U6 snRNPs and the spliced leader RNP. In addition, several U2 and U4/U6 snRNP-specific protein components were identified. Using monoclonal antibodies against human snRNP proteins, we could not detect any significant cross-reaction with the trypanosomal U2 snRNP proteins. Thus, the trypanosomal snRNPs exhibit principal differences from the higher eukaryotic snRNPs not only in their RNA but also in their protein components.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833773      PMCID: PMC52659          DOI: 10.1073/pnas.88.20.9097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Evidence for three distinct D proteins, which react differentially with anti-Sm autoantibodies, in the cores of the major snRNPs U1, U2, U4/U6 and U5.

Authors:  T Lehmeier; K Foulaki; R Lührmann
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

2.  The U6 small nuclear RNA from Trypanosoma brucei.

Authors:  C Tschudi; A R Krainer; E Ullu
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Monoclonal antibodies against the viral and human cellular myb gene product.

Authors:  H Bading; C Beutler; P Beimling; J Gerdes; H Stein; K Moelling
Journal:  Haematol Blood Transfus       Date:  1987

Review 5.  Spliceosomal snRNAs.

Authors:  C Guthrie; B Patterson
Journal:  Annu Rev Genet       Date:  1988       Impact factor: 16.830

6.  Trans splicing involves a novel form of small nuclear ribonucleoprotein particles.

Authors:  J P Bruzik; K Van Doren; D Hirsh; J A Steitz
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

7.  Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies.

Authors:  W J Habets; M H Hoet; B A De Jong; A Van der Kemp; W J Van Venrooij
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

8.  Trans-spliced leader RNA exists as small nuclear ribonucleoprotein particles in Caenorhabditis elegans.

Authors:  K Van Doren; D Hirsh
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

9.  Trypanosome mRNAs have unusual "cap 4" structures acquired by addition of a spliced leader.

Authors:  K L Perry; K P Watkins; N Agabian
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

10.  Purification of the individual snRNPs U1, U2, U5 and U4/U6 from HeLa cells and characterization of their protein constituents.

Authors:  P Bringmann; R Lührmann
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

View more
  28 in total

1.  Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin.

Authors:  J Salgado-Garrido; E Bragado-Nilsson; S Kandels-Lewis; B Séraphin
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Unconventional rules of small nuclear RNA transcription and cap modification in trypanosomatids.

Authors:  Christian Tschudi; Elisabetta Ullut
Journal:  Gene Expr       Date:  2002

Review 3.  trans and cis splicing in trypanosomatids: mechanism, factors, and regulation.

Authors:  Xue-hai Liang; Asaf Haritan; Shai Uliel; Shulamit Michaeli
Journal:  Eukaryot Cell       Date:  2003-10

4.  Domain structure of U2 and U4/U6 small nuclear ribonucleoprotein particles from Trypanosoma brucei: identification of trans-spliceosomal specific RNA-protein interactions.

Authors:  A Günzl; M Cross; A Bindereif
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

5.  Sm core variation in spliceosomal small nuclear ribonucleoproteins from Trypanosoma brucei.

Authors:  Pingping Wang; Zsofia Palfi; Christian Preusser; Stephan Lücke; William S Lane; Christian Kambach; Albrecht Bindereif
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

6.  Spliced leader RNA gene transcription in Trypanosoma brucei requires transcription factor TFIIH.

Authors:  Ju Huck Lee; Tu N Nguyen; Bernd Schimanski; Arthur Günzl
Journal:  Eukaryot Cell       Date:  2007-01-26

7.  SMN-assisted assembly of snRNP-specific Sm cores in trypanosomes.

Authors:  Zsofia Palfi; Nicolas Jaé; Christian Preusser; Katarzyna H Kaminska; Janusz M Bujnicki; Ju Huck Lee; Arthur Günzl; Christian Kambach; Henning Urlaub; Albrecht Bindereif
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

8.  Evidence for the presence of a small U5-like RNA in active trans-spliceosomes of Trypanosoma brucei.

Authors:  J M Dungan; K P Watkins; N Agabian
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

9.  Spliced leader RNA of trypanosomes: in vivo mutational analysis reveals extensive and distinct requirements for trans splicing and cap4 formation.

Authors:  S Lücke; G L Xu; Z Palfi; M Cross; V Bellofatto; A Bindereif
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

10.  Trans mRNA splicing in trypanosomes: cloning and analysis of a PRP8-homologous gene from Trypanosoma brucei provides evidence for a U5-analogous RNP.

Authors:  S Lücke; T Klöckner; Z Palfi; M Boshart; A Bindereif
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.